Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker

Universitaire Ziekenhuizen KU Leuven

Status: Enrolling

Conditions: Skin Cancer Melanoma; Skin Cancer, Non-Melanoma

Treatments: Other: Collection of Human Body Material and Clinical Data

Study type: Observational

Funder types: Other

Identifiers

NCT07266142

S70567

Details and patient eligibility

About

The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma and non-melanoma skin cancer.

The main questions it aims to answer are:

• To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma and non-melanoma.
• To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols).

If there is a comparison group: Not applicable (umbrella protocol for collection only).

Participants will:

• Share demographics, medical and surgical history, risk factors.

• Complete Cancer Worry Scale questionnaire.

• Provide biological samples:

  • Blood samples (serum, plasma, DNA).
  • Tissue samples (residual tissue or additional biopsy if consented).

Enrollment: 7,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
• Adult subjects (>18 years of age) at time of enrolment.
• Subjects diagnosed with cutaneous melanoma or Non-melanoma skin cancer.
• Adult subjects able and willing to provide informed consent.

Exclusion criteria

• Subjects unable or not willing to provide informed consent.
• Pregnancy (or willing to become pregnant) is NOT an exclusion criteria (unless specified in the respective satellite protocols.

Trial design

7,500 participants in 1 patient group

Biobank Collection Arm

Description:

Participants diagnosed with cutaneous melanoma or non-melanoma skin cancer will provide informed consent for collection and long-term storage of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and associated clinical data for future research.

Treatment:

Other: Collection of Human Body Material and Clinical Data